Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA, Industry To Iron Out Branding Provision Concerns Under MDUFMA

This article was originally published in The Gray Sheet

Executive Summary

Implementation of device branding practices that are cost-effective and do not compromise safety and efficacy will require administrative solutions generated by manufacturers and FDA, according to Latham & Watkins Associate John Manthei

You may also be interested in...



MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance

FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance

Device Reuse: 510(k) Exemptions Terminated, Validation Guidance Awaited

FDA is retaining its 510(k)-exempt status for non-electric biopsy forceps, despite a further layer of scrutiny afforded by the Medical Device User Fee & Modernization Act

Real World Data Failed To Impress Kaftrio’s European Reviewers

The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.

UsernamePublicRestriction

Register

OM011382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel